- Home
- / Greenwich Biosciences
Greenwich Biosciences
Greenwich Biosciences Summary
Company Summary
- Overview
- Greenwich Biosciences is a biopharmaceutical company that develops cannabinoid prescription medicines. It offers EPIDIOLEX (cannabidiol), a prescription formulation of highly purified, plant-derived cannabidiol (CBD).
- Type
- Subsidiary
- Status
- Active
- Founded
- 2013
- HQ
- Carlsbad, CA, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Darren Cline, Chief Commercial Officer
Scott Giacobello, Chief Financial Officer
Volker Knappertz, Chief Medical Officer
